These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P, Working Group on Perioperative Haemostasis. Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130 [Abstract] [Full Text] [Related]
3. Acute management of bleeding in patients on novel oral anticoagulants. Siegal DM, Crowther MA. Eur Heart J; 2013 Feb; 34(7):489-498b. PubMed ID: 23220847 [Abstract] [Full Text] [Related]
4. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications. Fenger-Eriksen C, Münster AM, Grove EL. Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468 [Abstract] [Full Text] [Related]
5. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future]. Dumont B, Faille D, Ajzenberg N. Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670 [Abstract] [Full Text] [Related]
6. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Firriolo FJ, Hupp WS. Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):431-41. PubMed ID: 22668425 [Abstract] [Full Text] [Related]
7. New oral anticoagulants: will they replace warfarin? Little JW. Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):575-80. PubMed ID: 22668618 [Abstract] [Full Text] [Related]
8. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience. Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358 [Abstract] [Full Text] [Related]
9. [Rivaroxaban: mode of action]. Drouet L. Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786 [Abstract] [Full Text] [Related]
10. Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Herrmann R, Thom J, Wood A, Phillips M, Muhammad S, Baker R. Thromb Haemost; 2014 May 05; 111(5):989-95. PubMed ID: 24352511 [Abstract] [Full Text] [Related]
11. Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists. Levy JH. Clin Lab Med; 2014 Sep 05; 34(3):443-52. PubMed ID: 25168936 [Abstract] [Full Text] [Related]
14. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation]. Gorzelak-Pabiś P, Duraj I, Szlagowska L, Ciastkowska A, Broncel M. Pol Merkur Lekarski; 2014 Nov 05; 37(221):261-4. PubMed ID: 25546985 [Abstract] [Full Text] [Related]
15. [Expanded arsenal in atrial fibrillation: bye-bye marcumar?]. MMW Fortschr Med; 2012 Jan 19; 154(1):20. PubMed ID: 22641998 [No Abstract] [Full Text] [Related]